微型RNA市场规模、份额和成长分析（按产品、服务、应用、最终用途和地区划分）－2026-2033年产业预测

预计到 2024 年，全球微型RNA市场规模将达到 15.2 亿美元，到 2025 年将达到 17.2 亿美元，到 2033 年将达到 45.3 亿美元，在预测期（2026-2033 年）内，复合年增长率为 12.9%。

全球微型RNA市场正经历显着成长，这主要得益于癌症、心臟病和神经系统疾病发病率的上升，以及基因组技术的快速发展。 microRNA存在于多种体液中，已成为有效的疾病监测中极具价值的非侵入性生物标记。 microRNA在基因调控过程中发挥关键作用，其在血清和血浆中的稳定性增强了其诊断和预后潜力，使其成为多种人类疾病的强效生物标记。此外，存在于外泌体中的循环微型RNA可提供重要的免疫状态数据，进一步证实了其作为健康状况指标的重要性。人们对微型RNA在疾病诊断中的作用认识不断提高，其效用广泛，这支撑了强劲的市场需求，并推动了整个微型RNA产业的蓬勃发展。

全球微型RNA市场驱动因素

全球微型RNA市场正受到公共和企业对基因组研究投入激增的显着影响。这些资金支持正推动人们对微型RNA调控基因功能及其在多种疾病中的作用机制进行更深入的了解。因此，以微型RNA应用为中心的诊断和治疗方法研发正在加速推进。资金的涌入不仅推动了创新，也促进了合作研究计划的发展，为微型RNA在临床实践中的应用铺平了道路。这些进展对于改善患者照护和充分发挥微型RNA技术在医疗保健领域的潜力至关重要。

限制全球微型RNA市场的因素

微型RNA的生物学复杂性对全球微型RNA市场构成重大挑战。这种复杂性源自于微RNA分子作用机制的多样性、与各种生物成分的相互作用，以及不同组织间的差异。这种多方面的生物学特性阻碍了特定治疗标靶的精准识别，也使得科学发现转化为实际应用变得更加复杂。因此，由于研究人员和开发人员面临这些根本性的复杂性，标靶治疗的开发困难可​​能会抑制整个微型RNA市场的成长和发展。

全球微型RNA市场趋势

全球微型RNA市场正经历着向联合疗法的重大转变，其驱动力在于提高治疗效果和克服抗药性。这一趋势强调将传统治疗方法与基于微型RNA的方法相结合，从而实现更全面的疾病治疗策略。研究人员日益关注微型RNA与各种生物路径相互作用的能力，不仅有助于提高现有药物的疗效，还能促进整体治疗方案的开发。随着我们对微型RNA功能的理解不断加深，利用其独特能力开发创新疗法的潜力正成为市场的核心主题。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球微型RNA市场规模（依产品及复合年增长率划分）（2026-2033年）

• 装置
  • 科技
  • 即时PCR
  • 微阵列
  • 次世代定序（NGS）
  • 其他的
  • 工作流程
  • 分离/纯化
  • miRNA cDNA合成
  • 分析、定位和定量
  • 函数分析及其他
  • 其他的
• 消耗品
  • 检体
  • 工作流程
  • 分离/纯化
  • miRNA cDNA合成
  • 分析、定位和定量
  • 函数分析及其他
  • 其他的
  • 全血
  • 血清
  • 电浆
  • FFPE
  • 新鲜冷冻组织
  • 其他的

全球微型RNA市场规模（按服务类型和复合年增长率划分）（2026-2033年）

• 按类型
  • 分离/纯化
  • miRNA cDNA合成
  • 分析、定位和定量
  • 功能分析
  • 其他的
• 检体
  • 全血
  • 血清
  • 电浆
  • FFPE
  • 新鲜冷冻组织
  • 其他的

全球微型RNA市场规模（依应用及复合年增长率划分）（2026-2033年）

• 癌症
• 感染疾病
• 免疫疾病
• 心血管疾病
• 神经系统疾病
• 其他的

全球微型RNA市场规模（按最终用途和复合年增长率划分）（2026-2033年）

• 生物技术和製药公司
• 学术和政府研究机构
• 其他的

全球微型RNA市场规模及复合年增长率（2026-2033年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Thermo Fisher Scientific（US）
• QIAGEN（Germany）
• Illumina（US）
• Takara Bio（Japan）
• New England Biolabs（UK）
• NanoString Technologies（US）
• Merck KGaA（Germany）
• Horizon Discovery（UK）
• GeneCopoeia（US）
• Bio-Rad Laboratories（US）
• LGC Limited（UK）
• BioGenex（US）
• PerkinElmer（US）
• Agilent Technologies（US）
• Roche Holding AG（Switzerland）
• System Biosciences（US）
• MiRXES（Singapore）
• aceRNA Technologies（Japan）
• ARTHEx Biotech（Spain）

结论与建议

Global MicroRNA Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.72 Billion in 2025 to USD 4.53 Billion by 2033, growing at a CAGR of 12.9% during the forecast period (2026-2033).

The global microRNA market is witnessing significant growth driven by the increasing prevalence of cancer, heart disease, and neurological disorders, alongside rapid advancements in genomic technologies. MicroRNAs have emerged as valuable noninvasive biomarkers, as their presence in various bodily fluids enables effective disease monitoring. Recognized for their crucial role in gene regulatory processes, miRNAs serve as strong biomarkers for numerous human disorders, with their stability in serum and plasma enhancing their diagnostic and prognostic potential. Additionally, circulating miRNAs within exosomes provide insightful data on immunological conditions, reinforcing their importance as indicators of health status. This expanding recognition and utility of microRNAs in disease diagnostics underpin the robust market demand, propelling the overall growth of the microRNA industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MicroRNA market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MicroRNA Market Segments Analysis

Global MicroRNA Market is segmented by Products, Services, Application, End-use and region. Based on Products, the market is segmented into Instruments and Consumables. Based on Services, the market is segmented into Type and Specimen. Based on Application, the market is segmented into Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease and Others. Based on End-use, the market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MicroRNA Market

The Global MicroRNA market is significantly influenced by the surge in public and corporate funding directed towards genomic research. This financial support is enhancing our understanding of how microRNAs regulate gene functions and contribute to various diseases. As a result, there is an accelerated development of diagnostics and treatments centered around microRNA applications. This influx of funding not only advances innovation but also promotes collaborative research projects, paving the way for the integration of microRNAs into clinical practices. Such advancements are crucial for enhancing patient care and harnessing the full potential of microRNA technology in the medical field.

Restraints in the Global MicroRNA Market

The intricate nature of MicroRNA biology poses a significant challenge for the global microRNA market. The complexities arise from the diverse modes of action and interactions these molecules exhibit with various biological components, along with the variability observed across different tissues. This multifaceted biology can hinder the precise identification of specific treatment targets, complicating the translation of scientific discoveries into practical applications. As a result, the difficulties in developing targeted therapies may restrain the overall growth and advancement of the microRNA market, as researchers and developers grapple with these underlying complexities.

Market Trends of the Global MicroRNA Market

The Global MicroRNA market is witnessing a significant shift towards combination therapies, driven by the quest for enhanced treatment outcomes and the need to overcome drug resistance. This trend emphasizes the integration of traditional treatments alongside microRNA-based approaches, allowing for a more multifaceted strategy in addressing diseases. Researchers are increasingly focusing on the ability of microRNAs to interact with various biological pathways, thereby not only improving the efficacy of existing pharmaceutical options but also promoting a holistic therapeutic approach. As the understanding of microRNA functions deepens, the potential for innovative treatments leveraging their unique capabilities is becoming a central theme in the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global MicroRNA Market Size by Products & CAGR (2026-2033)

• Market Overview
• Instruments
  • Technology
  • Real Time PCR
  • Microarray
  • NGS
  • Others
  • Workflow
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis & Others
  • Others
• Consumables
  • Specimen
  • Workflow
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis & Others
  • Others
  • Whole Blood
  • Serum
  • Plasma
  • FFPE
  • Fresh Frozen Tissue
  • Others

Global MicroRNA Market Size by Services & CAGR (2026-2033)

• Market Overview
• Type
  • Isolation & Purification
  • miRNA cDNA Synthesis
  • Profiling, Localization, & Quantification
  • Functional Analysis
  • Others
• Specimen
  • Whole Blood
  • Serum
  • Plasma
  • FFPE
  • Fresh Frozen Tissue
  • Others

Global MicroRNA Market Size by Application & CAGR (2026-2033)

• Market Overview
• Cancer
• Infectious Diseases
• Immunological Disorder
• Cardiovascular Disease
• Neurological Disease
• Others

Global MicroRNA Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Others

Global MicroRNA Market Size & CAGR (2026-2033)

• North America (Products, Services, Application, End-use)
  • US
  • Canada
• Europe (Products, Services, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Products, Services, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Products, Services, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Products, Services, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Discovery (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneCopoeia (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MiRXES (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• aceRNA Technologies (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARTHEx Biotech (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations